Public Health Surveillance for the Prevention of Complications of Bleeding and Clotting Disorders

Clinical Trial Title

Public health surveillance for the prevention of complications of bleeding and clotting disorders.

Clinical Trial Protocol Description:

HIV and hepatitis C screening. Lab draws for testing inhibitors.

Clinical Trial Eligibility Criteria:

In order to participate you must meet the following criteria:

  • Have hemophilia, von Willebrand disease, or another bleeding disorder.
  • Have received blood based product via infusion/transfusion.

This is a partial list of elgibility requirements.

Study Details

Clinical Trial Investigator

Lisa Boggio, MD

Contact Information

Lisa Boggio, MD

(312) 942-3034